Geneos Therapeutics Secures $17 Million In Series A2 Financing To Advance Personalized Cancer Immunotherapy Platform
Amount Raised
$17 Million
Round Type
Series A
Plymouth MeetingBiotechnologyHealth CareScience And EngineeringDescription
Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of tumor neoantigen targeted personalized immunotherapies, announced today that it has secured $17 million in Series A2 financing. The financing was led by Flerie Invest with participation from all existing Series A investors including Santé Ventures, Korea Investment Partners (KIP) – Global Bio Fund, and INOVIO Pharmaceuticals, Inc. (NASDAQ: INO). In conjunction with the financing, Dr
Quick answer
Geneos Therapeutics raised $17 Million in a Series A round, dated March 24, 2022. Geneos Therapeutics is based in Plymouth Meeting, Pennsylvania, United States.
- How much did Geneos Therapeutics raise?
- Geneos Therapeutics raised $17 Million in a Series A round on March 24, 2022.
- What does Geneos Therapeutics do?
- Geneos Therapeutics, a privately held, clinical stage biotherapeutics company, believes that the company's personalized therapeutic cancer vaccines (PTCVs) may serve an important role in new immunotherapeutic paradigms..
- Where is Geneos Therapeutics based and how big is it?
- Geneos Therapeutics is based in Plymouth Meeting, Pennsylvania, United States.
- Who are the decision-makers at Geneos Therapeutics?
- Fundz holds 2 contacts at Geneos Therapeutics, including the Vice President Head Of Operations Business Development. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Geneos Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Hemispherian AS raised an undisclosed amount (Seed) on May 3, 2022.
- Haya Therapeutics raised an undisclosed amount (Funding Round) on May 3, 2022.
- Engimmune Therapeutics raised an undisclosed amount (Seed) on May 3, 2022.
- IMPLICITY raised $23M (Funding Round) on April 27, 2022.
- Unlearn raised $50M (Series B) on April 19, 2022.
- Unlearn raised $50M on April 19, 2022.
Who to call at Geneos Therapeutics, and when
A new round usually means Geneos Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Geneos Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Geneos Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Geneos Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Geneos Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGeneos Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.